Seeing Is Believing
ALNY is currently covered by 22 analysts with an average price target of $507.69. This is a potential upside of $42.74 (9.19%) from yesterday's end of day stock price of $464.95.
Alnylam Pharmaceuticals's activity chart (see below) currently has 592 price targets and 482 ratings on display. The stock rating distribution of ALNY is 90.77% BUY and 9.23% HOLD.
Analysts average stock forecasts to be materialized ratio is 92.5% with an average time for these price targets to be met of 227.31 days.
Highest price target for ALNY is $583, Lowest price target is $296, average price target is $428.
Most recent stock forecast was given by PAUL MATTEIS from STIFEL on 06-Oct-2025.
Currently out of the existing stock ratings of ALNY, 59 are a BUY (90.77%), 6 are a HOLD (9.23%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$495
$34.54 (7.50%)
$345
7 days ago
(06-Oct-2025)
18/19 (94.74%)
$43 (9.51%)
240
Hold
$475
$14.54 (3.16%)
$268
7 days ago
(06-Oct-2025)
10/11 (90.91%)
$23 (5.09%)
39
Buy
$500
$39.54 (8.59%)
$330
24 days ago
(19-Sep-2025)
23/24 (95.83%)
$46.44 (10.24%)
209
Buy
$520
$59.54 (12.93%)
$359
26 days ago
(17-Sep-2025)
10/11 (90.91%)
$68.27 (15.11%)
142
Buy
$566
$105.54 (22.92%)
$370
27 days ago
(16-Sep-2025)
8/10 (80%)
$104.76 (22.71%)
289
What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?